SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-002798
Filing Date
2020-02-14
Accepted
2020-02-14 17:20:06
Documents
1
Period of Report
2020-02-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K innv20200214_8k.htm 8-K 37178
  Complete submission text file 0001437749-20-002798.txt   38867
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52991 | Film No.: 20621991
SIC: 2834 Pharmaceutical Preparations